These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24520542)

  • 21. The effects of microRNAs on glucocorticoid responsiveness.
    Wang H; Gou X; Jiang T; Ouyang J
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1005-1011. PubMed ID: 28286901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids.
    Miller AL; Komak S; Webb MS; Leiter EH; Thompson EB
    Cancer Cell Int; 2007 Nov; 7():18. PubMed ID: 18045478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid receptors in adult acute lymphoblastic leukemia.
    Bloomfield CD; Smith KA; Peterson BA; Munck A
    Cancer Res; 1981 Nov; 41(11 Pt 2):4857-60. PubMed ID: 6945909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of recombinant cell-permeable small peptides to modulate glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
    Geng CD; Vedeckis WV
    Biochemistry; 2010 Oct; 49(41):8892-901. PubMed ID: 20831260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.
    Beesley AH; Rampellini JL; Palmer ML; Heng JY; Samuels AL; Firth MJ; Ford J; Kees UR
    Mol Cancer; 2010 Oct; 9():284. PubMed ID: 20979663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
    Sai S; Nakagawa Y; Yamaguchi R; Suzuki M; Sakaguchi K; Okada S; Seckl JR; Ohzeki T; Chapman KE
    Leuk Res; 2011 Dec; 35(12):1644-8. PubMed ID: 21794917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated bioinformatics analysis of the crucial candidate genes and pathways associated with glucocorticoid resistance in acute lymphoblastic leukemia.
    Chen Y; Jiang P; Wen J; Wu Z; Li J; Chen Y; Wang L; Gan D; Chen Y; Yang T; Lin M; Hu J
    Cancer Med; 2020 Apr; 9(8):2918-2929. PubMed ID: 32096603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia.
    Poulard C; Kim HN; Fang M; Kruth K; Gagnieux C; Gerke DS; Bhojwani D; Kim YM; Kampmann M; Stallcup MR; Pufall MA
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3052-3061. PubMed ID: 30733284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
    Beesley AH; Firth MJ; Ford J; Weller RE; Freitas JR; Perera KU; Kees UR
    Br J Cancer; 2009 Jun; 100(12):1926-36. PubMed ID: 19436302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple forms and fragments of cytosolic glucocorticoid receptors from human leukemic cells and normal lymphocytes.
    Sherman MR; Stevens YW; Tuazon FB
    Cancer Res; 1984 Sep; 44(9):3783-96. PubMed ID: 6589045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of the dual-luciferase report assay for predicting response to glucocorticoid in children with acute lymphoblastic leukemia.
    Wang X; Chen P; Sun Y; Chen Y; Mao M; Jiang T; Ouyang J
    Clin Transl Oncol; 2017 Oct; 19(10):1241-1246. PubMed ID: 28444640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
    Meyer LK; Delgado-Martin C; Maude SL; Shannon KM; Teachey DT; Hermiston ML
    PLoS One; 2019; 14(7):e0220026. PubMed ID: 31318944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells.
    Schlossmacher G; Stevens A; White A
    J Endocrinol; 2011 Oct; 211(1):17-25. PubMed ID: 21602312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoid resistance in childhood leukemia.
    Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ
    Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation.
    Sciarrillo R; Wojtuszkiewicz A; Kooi IE; Leon LG; Sonneveld E; Kuiper RP; Jansen G; Giovannetti E; Kaspers GJL; Cloos J
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32204435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia.
    Serafin V; Capuzzo G; Milani G; Minuzzo SA; Pinazza M; Bortolozzi R; Bresolin S; Porcù E; Frasson C; Indraccolo S; Basso G; Accordi B
    Blood; 2017 Dec; 130(25):2750-2761. PubMed ID: 29101238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
    Hala M; Hartmann BL; Böck G; Geley S; Kofler R
    Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staurosporine sensitizes T lymphoma cells to glucocorticoid-induced apoptosis: role of Nur77 and Bcl-2.
    Kfir S; Sionov RV; Zafrir E; Zilberman Y; Yefenof E
    Cell Cycle; 2007 Dec; 6(24):3086-96. PubMed ID: 18073527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional proteomics for the characterization of impaired cellular responses to glucocorticoids in asthma.
    Pazdrak K; Kurosky A
    Adv Exp Med Biol; 2014; 795():255-70. PubMed ID: 24162914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.
    Myoumoto A; Nakatani K; Koshimizu TA; Matsubara H; Adachi S; Tsujimoto G
    J Hum Genet; 2007; 52(4):328-333. PubMed ID: 17310274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.